Indoco Remedies Ltd.

NSE: INDOCO | BSE: 532612 | ISIN: INE873D01024 | Industry: Pharmaceuticals
| Slowing Down Stock
232.5700 5.88 (2.59%)
NSE Apr 30, 2025 15:31 PM
Volume: 32,762
 

232.57
2.59%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues declined 2.6% YoY to | 270 crore (I-direct estimate: | 275 crore). Export formulations declined 17% YoY to | 88 crore (I-direct estimate: | 101 crore) while domestic formulations grew 16.1% to | 151 crore (I-direct estimate: | 154 crore) EBITDA margins increased 718 bps YoY to 18.9% (I-direct estimate of 14.0%) due to lower operational expenditure across line items. EBITDA rose 56.8% YoY to | 51 crore (I-direct estimate: | 39 crore)...
Indoco Remedies Ltd. has lost -28.65% in the last 1 Year
More from Indoco Remedies Ltd.
Recommended